Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Cash (2022 - 2025)

CervoMed's Change in Cash history spans 9 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Change in Cash rose 149.29% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $1.7 million, up 163.18%, while the annual FY2024 figure was $1.2 million, 67.38% down from the prior year.
  • Change in Cash for Q3 2025 was $1.1 million at CervoMed, up from -$2.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $29.5 million in Q3 2022 and bottomed at -$27.4 million in Q1 2022.
  • The 4-year median for Change in Cash is -$1.4 million (2024), against an average of $184737.5.
  • The largest annual shift saw Change in Cash plummeted 280.03% in 2023 before it skyrocketed 285.54% in 2024.
  • A 4-year view of Change in Cash shows it stood at -$692530.0 in 2022, then tumbled by 280.03% to -$2.6 million in 2023, then skyrocketed by 147.72% to $1.3 million in 2024, then fell by 11.08% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Change in Cash are $1.1 million (Q3 2025), -$2.2 million (Q2 2025), and $1.5 million (Q1 2025).